Spotlight Investment: Gemphire Therapeutics
May 8, 2015
Novel drugs developer to treat unmet medical needs of patients with high cardiovascular and pancreatitis risks with goals beyond those of current therapies.
Spotlight Investment: HistoSonics
August 1, 2011
Histotripsy is a non-invasive soft tissue ablation modality that mechanically homogenizes target tissue resulting in complete cellular destruction with no thermal injury.